HERNDON, Va., Nov. 7 /PRNewswire/ -- Mediatech, Inc., makers of the
brand cellgro(R), and GlobalStem, Inc. have recently formed a strategic
alliance to develop, manufacture, validate, and distribute Embryonic Stem
Cell-qualified growth media and supplements. Each company's core
competencies and strengths, when combined, create a mutually beneficial
synergy. Mediatech contributes over 20 years of cGMP experience in the
manufacture of sterile solutions while GlobalStem brings a wealth of
knowledge and research in the field of embryonic stem cells (ESC).
    Pluripotent ES cells are capable of self-renewal while maintaining the
malleability to differentiate into other major cell types in the body. This
gives promise to the technology of cell replacement therapies aimed at
remedying disease such as diabetes, Parkinson's, spinal cord injuries and
stroke. Human ES cells also provide an excellent model for the study of
normal human development. Despite the rapid progress in recent years, there
still exists an unmet need among stem cell researchers for fully
characterized stem cell lines, validated feeder cells, qualified reagents
and characterization tools. The alliance formed between Mediatech and
GlobalStem hopes to bridge this gap and advance such a promising aspect of
medicine.
    About Mediatech, Inc.
    Mediatech, Inc. is a leading manufacturer and supplier of cell culture
and molecular biology reagents to biopharmaceutical, academic and
government research facilities, as well as biotechnology companies.
Mediatech prides itself on unprecedented levels of quality and rigid
release specifications for products. In addition to following current Good
Manufacturing Processes (cGMP) and complying with FDA Guidelines for Class
I Medical Devices, Mediatech is certified under ISO 13485:2003 and
compliant with ISO 17025:2001. Most recently, Mediatech was licensed as a
drug establishment for the production and distribution of WFI water.
Mediatech's facility design and Quality Assurance Systems guarantee low
endotoxin levels for both liquid and powdered products and meets the most
rigid Sterility Assurance Levels for liquid products. All cellgro(R) basal
media and salt solutions must test negative for mycoplasma prior to
release. For more information visit http://www.cellgro.com/.
    About GlobalStem, Inc.
    Founded in March 2006, GlobalStem, Inc. boasts a highly experienced,
well- trained staff of stem cell experts. Their mission is to accelerate
the advance of stem cell research through the development and distribution
of quality cell lines, products, services, and technical support.
GlobalStem aims to provide ESC-validated growth media, sera, supplements,
growth factors, and assay kits, in addition to being a comprehensive
resource center of cell lines, technical information, and technology
platforms for the universal stem cell research community. GlobalStem is
involved in the acquisition and derivation of stem cell lines, the
manufacturing, banking, and distribution of these cells, and development of
new research tools and for stem cell research. For more information visit

http://www.globalstem.com/.
    CONTACT: Lauren Supko, Marketing Associate of Mediatech, Inc.,
+1-703-471-5955, or lsupko@cellgro.com